P-27 South American experience with a 3-week regimen of gemcitabine(GEM) and cisplatin (CIS) in advanced NSCLC: Preliminary results
R.L. Ramirez Gomez, Sergio Santillana, Daniel Lee Kay Pen, José I. Martínez, Zulay Pastrán, Javier Afonso, Carlos Ortíz, A. López Jiménez(Instituto de Cancerología Las Américas), Eliécer Payares, Sergio Poli(Brigham and Women's Hospital)
Cited by 0
Related Papers
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
|Science Advances|2020|1.5k
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780
Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung
|Circulation|2021|473
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
|Journal of Clinical Oncology|2015|253
Single-cell connectomic analysis of adult mammalian lungs
|Science Advances|2019|243